SNDX — Syndax Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Syndax Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	61.1	298	447	484	578
Net Total Receivables	0.116	0.175	0.429	4.06	1.23
Prepaid Expenses
Total Other Current Assets
Total Current Assets	62.3	299	448	490	581
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.997	0.482	1.26	1.06	1.5
Long Term Investments
Other Long Term Assets
Total Assets	63.5	301	450	497	613
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18.4	18.9	20.7	29.1	58.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	31.9	48.4	41.3	29.8	58.7
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	31.6	252	408	467	554
Total Liabilities & Shareholders' Equity	63.5	301	450	497	613
Total Common Shares Outstanding